| Business

Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan posts a 17 percent drop in quarterly profit

Email Newsletters

Sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Thursday, May 2, 2013, 4:42 p.m.

Profit at generic drugmaker Mylan Inc. dropped 17 percent in the first quarter on higher research and development expenses, the company said on Thursday.

Cecil-based Mylan reported net income of $106.9 million, or 27 cents a share, down from $129.1 million, or 30 cents a share, in the same quarter a year ago.

The company spent $126.5 million on research and development, up from $81 million. Mylan Chief Financial Officer John Sheehan said the company is investing more to develop new products that will drive growth, including generic biologic drugs and respiratory products, such as inhalers for asthma and other breathing problems. Biologics are medicines that are derived from human proteins, instead of from chemicals.

Revenue was $1.63 billion, up from $1.58 billion.

CEO Heather Bresch said sales in Mylan's Specialty division rose 24 percent on the strength of its EpiPen product, an injector used in emergencies to treat severe allergic reactions.

On an adjusted basis, the company's earnings per share were 62 cents, up from 52 cents in the same quarter last year. Adjustments were for one-time payments such as litigation settlements, research licensing costs, acquisition-related costs and restructuring, the company said.

“Our first quarter results provide a strong start to the year and are fully in line with our expectations,” Bresch said in a written statement.

The company affirmed its full-year outlook for adjusted earnings per share of $2.75 to $2.95.

“We remain very confident in our outlook for our business in 2013,” Bresch said.

Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928 or

Add Alex Nixon to your Google+ circles.

Subscribe today! Click here for our subscription offers.




Show commenting policy

Most-Read Business Headlines

  1. Black Friday chaos dwindles thanks to earlier deals, online sales
  2. Employers cut back on holiday office parties
  3. Nimble Regal ready for winter with all-wheel drive
  4. Key gets stuck in ignition
  5. Convinced Fed will raise rates in December, investors parse meaning of ‘gradual’ increase
  6. Stocks close quiet week with little change
  7. Stop neighbors from stealing your Internet
  8. Fuel cell standoff slows car technology’s rise in popularity
  9. Small stores take big gamble by not upgrading credit card readers
  10. $170.4M AmEx charge yields whopping perk for Chinese billionaire
  11. GOP Senators Rubio, Cruz at odds on tougher surveillance law